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080 The Journal of Thoracic and Cardbjective: We sought to study the evolution of biventricular filling properties after
oronary artery bypass grafting.
ackground: The evolution of diastolic function as defined with newer echocardio-
raphic modalities after coronary artery bypass grafting surgery is unknown in
atients with preoperative left ventricular diastolic dysfunction.
ethods: Transthoracic echocardiography was performed preoperatively and 48
ours and 6 months after coronary artery bypass grafting in 49 patients (randomized
o milrinone [n  25]) or placebo [n  24]) with preoperative left ventricular
iastolic dysfunction classified according to published criteria. Mild right ventric-
lar diastolic dysfunction was defined as the ratio of early to atrial filling velocity
f less than 1 in transtricuspid flow or the velocity of reversed atrial flow of greater
han 50% of that of systolic flow in hepatic venous flow or the ratio of tricuspid
nnulus velocity during early and atrial filling of less than 1 if both the ratio of early
o atrial filling velocity and the ratio of systolic to diastolic velocity was greater than
in hepatic venous flow. Moderate right ventricular diastolic dysfunction was
iagnosed when there was a ratio of early to atrial filling velocity of greater than 1
ith a ratio of systolic to diastolic velocity of less than 1. Severe right ventricular
iastolic dysfunction was defined as a ratio of early to atrial filling velocity of
reater than 1 associated with reversed systolic wave in hepatic venous flow.
esults: Moderate and severe left ventricular diastolic dysfunction increased from
reoperatively to 48 hours after coronary artery bypass grafting from 8.2% to 53.7%
nd from 2.0% to 9.7%, respectively (P  .0001, 48 hours vs preoperatively for
oth), and the patterns at 6 months were similar to those observed preoperatively.
imilar evolution over time was found for right ventricular diastolic dysfunction.
onclusions: In patients with preoperative left ventricular diastolic dysfunction,
iventricular filling patterns are impaired initially but return to preoperative status 6
onths after coronary artery bypass grafting.
bnormalities in left ventricular diastolic function are prevalent in adult
cardiac surgical patients.1 Preoperative left ventricular diastolic dysfunction
(LVDD) increases the risk of complications in cardiac surgery,2 and a
estrictive pattern is associated with higher early postoperative mortality and mor-
idity and minimal improvement in left ventricular systolic function in patients
ndergoing coronary artery bypass grafting (CABG) surgery.3,4 A pseudonormal or
estrictive left ventricular filling pattern shortly after CABG predicts detrimental left
entricular remodeling and cardiac events in the long term after the operation.4
revious studies on the effect of CABG on left ventricular diastolic function have
ad conflicting results.5,6 The long-term influence of CABG on ventricular diastolic
erformance is not well known. Furthermore, much less attention was paid to right
iovascular Surgery ● May 2006
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CDentricular diastolic profile in this population. Therefore
his study aimed to evaluate the short- and long-term evo-
ution of biventricular diastolic performance in patients with
reoperative LVDD undergoing CABG surgery with the
ewer echocardiographic modalities and the more recent
lassification recommended by the American Society of
chocardiography.7,8 In addition, we also wanted to docu-
ent whether milrinone, an agent commonly used in car-
iac surgery, had persistent effects on diastolic dysfunction
fter treatment interruption.
ethods
fter obtaining approval from the Research and Ethics Commit-
ees of the Montreal Heart Institute and informed consent, 49 of 70
onsecutive patients undergoing elective CABG surgery with car-
iopulmonary bypass (CPB) and preoperative LVDD diagnosed
y means of echocardiography were studied prospectively. Pa-
ients were excluded if they had a pacemaker or if they were not in
inus rhythm because of the difficulty in interpreting diastolic
unction indexes in such patients. The patients were randomized to
ilrinone (n  25) or placebo (n  24) as part of a study on the
ntraoperative effect of milrinone, an agent commonly used in
ardiac surgery. The dosage of milrinone consisted of a bolus of 50
g/kg followed by a perfusion of 0.5 g kg1 · min1 started after
he induction of anesthesia and continuing until skin closure.
ransthoracic Echocardiography
erial transthoracic echocardiographic studies were performed
Abbreviations and Acronyms
A  atrial filling A-wave velocity
Am  late mitral annular velocity
Ar  reversed atrial flow
At  atrial filling tricuspid annular velocity
CABG  coronary artery bypass grafting
CPB  cardiopulmonary bypass
D  diastolic D-wave velocity
DT  E-wave deceleration time
E  early mitral filling E-wave velocity
Em  early mitral annular velocity
Et  early filling tricuspid annular velocity
HVF  hepatic venous flow
IVRT  isovolumic relaxation time
LVDD  left ventricular diastolic dysfunction
LVEF  left ventricular ejection fraction
PVF  pulmonary venous flow
PW  pulsed wave
RVDD right ventricular diastolic dysfunction
S  systolic S-wave velocity
TDI  tissue Doppler imaging
TMF  transmitral flow
TTF  transtricuspid flow
Vp  propagation velocityreoperatively and 48 hours and 6 months after CABG surgery o
The Journal of Thoracicy using harmonic imaging with a 2.5-MHz phased-array trans-
ucer and a standard echocardiographic system (Sonos 5500;
ewlett-Packard, Andover, Mass). As shown in Figure 1, an apical
-chamber view was recorded to measure left and right end-
ystolic atrial area and left and right ventricular end-diastolic areas.
ulsed-wave (PW) Doppler imaging was used to evaluate trans-
itral flow (TMF), transtricuspid flow (TTF), pulmonary venous
ow (PVF), and hepatic venous flow (HVF). Peak velocities in
arly filling (E) and atrial filling (A) were measured, and the E/A
atio was calculated in TMF and TTF; the peak velocities of
ystolic flow (S), diastolic flow (D), and reversed atrial flow (Ar)
ere measured in PVF and HVF, and the S/D ratio was calculated.
eft ventricular isovolumic relaxation time (IVRT) was measured
ith continuous-wave Doppler scanning at the conjunction of left
entricular inflow and outflow and was corrected by the square
oot of R-R interval (IVRT/[RR]1/2) on simultaneously recorded
lectrocardiograms. Mitral annulus velocities during early filling
Em) and atrial filling (Am) and those of the tricuspid annulus (Et,
t) were derived by means of tissue Doppler imaging (TDI), and
itral flow propagation velocity (Vp) was studied with color
-mode scanning, as previously described.7,9 Ratios of E/Em and
/Vp were calculated for the left ventricle. The average of 3
onsecutive cardiac cycles was used for each measurement. Spe-
ial care was taken to obtain similar imaging planes on serial
xaminations by reviewing the previous recordings before the
ollow-up study for each patient.
To validate our measurements, we subjected 10 echocardio-
rams to 3 repeated measurements in a blinded fashion, with 3
onsecutive cardiac cycles analyzed for each recording. The coef-
cient of variation (SD  mean  100%) between 3 consecutive
ardiac cycles of the 10 echocardiograms was 2.7%  1.6% and
.5%  1.8% for the left and right atrial areas in cardiac systole
nd 3.4%  1.4% and 4.4%  1.9% for the left and right ven-
ricular end-diastolic areas, respectively. For PW velocity, IVRT,
DI velocity, and Vp, the coefficients of variation were 5.4% 
.6%, 3.8%  1.6%, 2.6%  1.3%, and 7.6%  3.5%, respec-
ively. The coefficient of variation between the 3 results based on
he average of 3 cycles of these 10 echocardiograms was 1.4% 
.8% and 2.7%  1.8% for the left and right atrial areas in cardiac
ystole and 2.9%  1.1% and 2.9%  1.1% for the left and right
entricular end-diastolic areas, respectively. For PW velocity,
VRT, TDI velocity, and Vp, the coefficients of variation were
.1%  0.4%, 1.2%  0.4%, 1.0%  1.0%, and 3.0%  1.4%,
espectively.
LVDD was classified according to published criteria.8 Mild
VDD was defined by an E/A ratio of less than 1 in TMF or 1 
/A  2 with an S/D ratio of greater than 1 in PVF and an Em of
ess than 12.5 cm/s with Am greater than 12.5 cm/s. Moderate
VDD was considered present when the E/A ratio was greater than
with an S/D ratio of less than 1. Severe LVDD was diagnosed
hen the E/A ratio was greater than 2 with an S/D ratio of less than
. Right ventricular diastolic evaluation was based on a combina-
ion of transtricuspid and hepatic venous PW Doppler signals and
ricuspid annulus TDI signals.10 Mild right ventricular diastolic
ysfunction (RVDD) was defined by an E/A ratio of less than 1 in
TF or an E/A ratio of greater than 1 and an S/D ratio of greater
han 1 in HVF if the Ar wave was greater than 50% of S in HVF
r the Et/At ratio was less than 1. Moderate RVDD was considered
and Cardiovascular Surgery ● Volume 131, Number 5 1081
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transmitral flow; TTF, transtricuspid flow; Vp, velocity of propagation.
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A
CDresent when the E/A ratio was greater than 1 with an S/D ratio of
ess than 1. Severe RVDD was diagnosed when an E/A ratio of
reater than 1 was associated with reversal of the S wave in HVF.
tatistical Analysis
ll data are expressed as means  SD. To analyze the evolution
f the variables, mixed-model repeated-measures analyses of co-
ariance controlling for the baseline value11 were used to extract
he group  time interaction and the time and group main effects.
hen the group  time interaction was significant, which means
hat groups showed a significant difference in evolution, slice
ffect (also known as simple effect)12 analyses were performed to
valuate differences among groups at each time level and to test
he evolution of each group. These analyses were performed with
he mixed procedure of SAS 6.12 to handle missing data. A P
alue less than .05 was considered statistically significant. The
ilcoxon test was used to compare the distribution of frequencies
f both left and right ventricular diastolic function patterns (P 
0167 was considered significant).
esults
f the 49 patients studied, 37 were male and aged from 55
o 81 years (68.6 7.3 years), and 12 were female and aged
rom 51 to 81 years (69.0  9.5), with no significant age
ifference between male and female patients. The mean
arsonnet score13 was 10  5, and the mean preoperative
eft ventricular ejection fraction (LVEF) was 50%  14%,
ith 5 patients having LVEFs of less than 30%. A total of
2 thoracic grafts and 111 venous grafts were performed
uring CABG surgery. The mean bypass and crossclamp
imes were 74  22 and 46  18 minutes, respectively.
protinin was used in all patients, and a cold blood cardio-
legia technique was used.
Heart rate and body weight were significantly increased
from 65.9  11.6 to 81.4  15.2 beats/min and 80.4 
5.4 to 83.1  13.9 kg [n  45], respectively), and sys-
olic and diastolic blood pressure were significantly de-
reased (from 125.5  12.8 to 115.4  10.6 and 66.3  8.6
o 60.6  7.3 mm Hg [n  45], respectively) postopera-
ively, and they all returned to baseline levels at 6 months’
ollow-up. There was no significant difference in urea/
reatinine, creatine kinase, creatine kinase MB, and tropo-
in values between the milrinone and placebo groups at any
tage over the study course. One patient died in each group.
he main findings of our study are summarized in Figure 1.
eft Ventricular Diastolic Patterns
n the preoperative period the distribution of LVDD as
ssessed by the newer classification modalities described
bove was 0%, 89.8%, 8.2%, and 2.0% (n 49) for normal,
ild, moderate, and severe LVDD, respectively. It was 0%,
6.6%, 53.7%, and 9.7% (n  41) and 4.5%, 91.0%, 4.5%,
nd 0% (n  23) at 48 hours and 6 months after CABG
urgery, respectively (P  .0001 at 48 hours vs preopera-igure 1. Changes in biventricular cardiac dimensions and in Dopp-
er profiles before (A) and 48 hours (B) and 6 months (C) after
oronary revascularization. At 48 hours, an increase in both the left
nd right atrial size is observed. This is associated with a deterio-
ation in both the left and right ventricular diastolic parameters. At 6
onths, no significant difference is seen compared with the preop-
rative echocardiographic parameters. HVF, Hepatic venous flow;
A, left atrium; LV, left ventricle;MAV, mitral annular velocities; PVF,
ulmonary venous flow; RA, right atrium; RV, right ventricle; TMF,ively and 6 months). No significant difference in the degree
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CDf LVDD was observed between preoperative and 6-month
valuations, and no effect of milrinone was observed.
Cardiac chamber size over the study course derived
rom 2-dimensional echocardiography. Both left and right
trial areas were significantly increased postoperatively and
eturned to baseline levels at 6 months’ follow-up (from
0.3 3.4 to 24.5 4.8 to 21.8 4.4 cm2 and from 15.5 
.1 to 19.5  4.2 to 15.9  3.9 cm2, P  .05 for 48 hours
s preoperatively and 6 months). No significant changes in
he left and right ventricular size were found during the
tudy course. There was no significant difference in the
ardiac chamber size between the milrinone and placebo
roups at any stage over the study course, and the 2 groups
hared the same evolution.
Transmitral inflow pattern (Table E1). The transmitral
wave significantly increased and the A wave decreased,
eading to an increased E/A ratio, and E-wave deceleration
ime (DT) significantly shortened at 48 hours after CABG.
hese changes returned to baseline levels 6 months after the
peration. A shorter A-wave duration (P  .047) was ob-
erved at 6 months compared with that seen in the preop-
rative study. The milrinone group had a higher E/A ratio
nd a shorter A-wave duration than the placebo group at all
tages during the study course. However, the 2 groups
hared the same evolution.
Pulmonary venous flow (Table E2). At 48 hours after
ABG surgery, the D wave in the pulmonary vein signifi-
antly increased, leading to a decreased S/D ratio (P 
0001) postoperatively. The 6-month values returned to their
aseline levels. A shorter Ar-wave duration was found at 48
ours after CABG, and this remained unchanged 6 months
fter the operation.
Mitral annulus velocities (Em and Am) derived by TDI
Table E3). No significant changes were observed for Em,
m, or Em/Am ratio during the whole study course. The
ilrinone group had a higher Em and Em/Am ratio at
aseline and at all stages during the study course compared
ith the placebo group. However, the 2 groups shared the
ame evolution. E/Em ratio significantly increased at 48
ours (P  .03) and was lower at 6 months compared with
aseline (P  .02) and 48-hour (P  .001) values. No
ignificant difference in E/Em ratio was observed between
he milrinone and placebo groups.
Left ventricular IVRT (Table E4). The evolution of left
entricular IVRT derived from continuous-wave Doppler
maging and its heart rate–corrected value are described in
able E4. Both shortened 48 hours after CABG (P .05 for
oth) and returned to baseline levels at 6 months. There was
o significant difference in IVRT between the milrinone and
lacebo groups at any stage over the study course, and the
groups shared the same evolution.
Mitral flow Vp (Table E4). There were important in-reases in Vp 48 hours after CABG (P  .05 vs baseline), t
The Journal of Thoracicnd the values returned toward preoperative levels 6 months
fter. E/Vp significantly decreased 48 hours after CABG
nd returned toward baseline 6 months later.
Right ventricular diastolic patterns. The distribution of
ormal, mild, moderate, and severe RVDD was 0%, 91.3%,
.5%, and 2.2% (n  46) preoperatively; 2.6%, 53.8%,
0.5%, and 23.1% (n  39) at 48 hours; and 9.1%, 86.4%,
.5%, and 0% (n  22) at 6 months (P  .002 for 48 hours
s preoperatively and P .01 for 48 hours vs 6 months). No
ignificant difference in the degree of RVDD was observed
etween the preoperative and 6-month evaluations. Milri-
one had no effect on the evolution of right ventricular
iastolic filling patterns.
Transtricuspid inflow (Table E5). The transtricuspid E
ave significantly increased at 48 hours and stayed at this
igh level 6 months after CABG surgery. Significantly
horter E-wave deceleration times were observed at both the
8-hour and 6-month evaluations compared with those at
he preoperative study (P  .05). There was a higher E/A
atio in the milrinone group than in the placebo group at
aseline and at all stages during the study course, and the 2
roups shared the same evolution.
Hepatic venous flow (Table E6). The S wave and the
/D ratio significantly decreased from baseline to 48 hours
fter CABG. There was no significant difference in any of
he parameters studied in HVF between the milrinone and
lacebo groups at any stage over the study course, and the
groups shared the same evolution.
Tricuspid annulus velocities derived from TDI
Table E7). The tricuspid annulus velocities Et and At
ignificantly decreased at 48 hours after CABG surgery, and
hey stayed at this lower level 6 months later. An increased
t/At ratio was observed at 48 hours after CABG and
eturned to preoperative levels 6 months later. There was no
ignificant difference in Et, At, and Et/At ratio between the
ilrinone and placebo groups at any stage over the study
ourse, and the 2 groups shared the same evolution.
iscussion
ur study showed that in patients with LVDD before
ABG, both left and right ventricular diastolic performance
ere impaired early after CABG surgery but returned to
reoperative filling status 6 months after CABG, as assessed
y using the newer echocardiographic modalities to classify
iastolic function. This evolution is not altered with intra-
perative milrinone.
tudies on Left Ventricular Diastolic Function in
atients Undergoing CABG
oppler echocardiography has been used in previous stud-
es to evaluate left ventricular filling in patients undergoing
ABG surgery, with quite similar findings but conflicting
nterpretation of postoperative left ventricular diastolic func-
ion. Lawson and colleagues5 observed increased E waves
and Cardiovascular Surgery ● Volume 131, Number 5 1083
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1
A
CDnd decreased A waves 1 week after CABG, which were of
he same order as we found at 48 hours. Those investigators
oncluded that CABG resulted in normalization of early
lling and decreased reliance on active atrial transport,
mplying improved left ventricular diastolic function by
ABG. In the study of van der Maaten and colleagues,14
ncreased E and A waves were observed postoperatively and
eturned to baseline values 4 hours after CABG, but changes
n these velocities did not result in decreased E/A ratios.
hey concluded that diastolic function was preserved after
ABG surgery in patients with preserved left ventricular
ystolic function. In selected patients with good preopera-
ive systolic left ventricular function, Houltz and associ-
tes15 found that the E/A ratio was unchanged during
ABG and concluded that both the active and passive
omponents of left ventricular diastolic function are well
aintained shortly after CABG and cardioplegic arrest. In
nother study16 TMF and PVF were evaluated by means of
ransesophageal echocardiography, and the evolution of the
- and A-wave velocities over time was similar to those
bserved in our study. Djaiani and coworkers17 used Vp to
dentify patients with abnormal diastolic function during
ABG surgery. They studied TMF and PVF profiles, as
ell as IVRT; found that LV filling patterns did not change
ignificantly after CPB; and concluded that Vp of less than
0 cm/s identified abnormal diastolic function in this patient
opulation. In the study of Gorcsan and colleagues18 on
MF in patients undergoing CABG, left ventricular dia-
tolic function worsened shortly after CABG surgery but
mproved at 20 hours follow-up. In a study by Wehlage and
oworkers,6 the contribution of early diastolic filling to left
entricular filling decreased from 55% to 35% during sur-
ical intervention. Furthermore, Ekery and associates19 re-
orted that LVDD after CABG is a frequent finding of
linical significance that persists at least 3 hours after the
peration. Finally, in another study20 changes in myocardial
elocities derived by using TDI indicated impairment in left
entricular diastolic function immediately after CABG.
The assessment of changes in left ventricular diastolic
unction after CABG surgery in these previous studies,
owever, was based on interpretation of individual echocar-
iographic parameters, and diastolic function was not clas-
ified according to the newer criteria. Most of the individual
oppler echocardiographic parameters are heart rate and
oad dependent, and the integration of the different changes
n diastolic parameters must be performed for correct inter-
retation. Normalization of one parameter, such as TMF,
aken in isolation could indicate improved or deteriorating
iastolic function, such as that observed in a pseudonormal
attern.8 Our study is therefore the first to use a combination
f 2-dimensional, pulsed Doppler echocardiography and the
ewer echocardiographic modalities to classify diastolic
unction. We found that 48 hours after CABG surgery, left i
084 The Journal of Thoracic and Cardiovascular Surgery ● Matrial dilatation, changes in TMF profile, increased E and
/A ratio, shortened deceleration time, and decreased S/D
atio revealed a shift of filling patterns from delayed relax-
tion to pseudonormal or restrictive patterns. The increase
f E/Em ratio, which is used to estimate left ventricular end-
iastolic pressure at 48 hours, supports this deterioration of
eft ventricular diastolic function. Our study also found that
he mitral Vp increased at 48 hours. A pseudonormal filling
attern and an LVEF of greater than 60% have been found
o be significant predictors of false-negative results with Vp
n predicting LVDD (P  .05),21 which could explain this
nding.
tudies on Right Ventricular Diastolic Function in
atients Undergoing CABG
erioperative right ventricular function is another potential
redictor of postoperative morbidity and mortality for pa-
ients undergoing CABG surgery.22,23 It is well known that
ABG surgery can impair right ventricular systolic func-
ion,24 and right ventricular systolic dysfunction is associ-
ted with a high in-hospital mortality rate.25 However, the
ffect of CABG on the natural evolution of right ventricular
iastolic properties using all the available echocardio-
raphic modalities has not been described. Alam and col-
eagues26 used TDI to study right ventricular diastolic filling
efore and after CABG and found that Et was significantly
educed 1 month and 1 year after CABG. However, evalu-
tion of HVF, which provides unique insight into right
entricular dynamics, was not recorded. Reduced S/D ratio
mmediately after CABG has been correlated with increased
ulmonary artery diastolic and RA pressure after CABG
urgery.27,28 In our study, using 2-dimensional echocardio-
raphic and Doppler-derived HVF, TTF, and TDI values,
e observed that right ventricular diastolic filling was im-
aired early after CABG surgery but improved 6 months
ater. Indeed, early postoperative right ventricular diastolic
eterioration was associated with right atrial dilatation and
bnormal TTF, HFV, and TDI values. Despite persistent
ncreased TTF E waves, shortened deceleration time, and
ecreased Et after CABG surgery, there was normalization
f right atrial dimensions and HVF at 6 months. Improve-
ent in HVF was also observed 6 months after CABG
urgery by Wranne and coworkers.29 These changes in biven-
ricular diastolic function could be explained by several
tructural and dynamic factors,30 including the cardioplegia
olution,17,31 the intraoperative ischemia commonly associ-
ted with relaxation abnormalities,5 and possibly reperfu-
ion injury.31
ffect of Milrinone
ilrinone was administered intraoperatively, and no differ-
nce was observed in the postoperative evolution of biven-
ricular diastolic properties. Phosphodiesterase inhibitors
mprove the response to -adrenergic drugs and can poten-
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A
CDiate the effects of dobutamine.32 In addition, milrinone has
een demonstrated to improve diastolic performance in
atients with congestive heart failure,33 left ventricular
ompliance after CPB,34,35 and cardiac output and myocar-
ial performance measured with transesophageal echocar-
iography.35,36 The absence of a residual effect on diastolic
unction at 48 hours could be explained by the short-term
se of this drug in the operating room.
imitations
emodynamic data were not obtained together with echo-
ardiographic evaluation of diastolic profiles. Our conclu-
ions apply to patients undergoing elective coronary revas-
ularization during CPB with preoperative LVDD. The
atients were followed up for 6 months, and therefore a
ore marked effect of CABG on diastolic performance
ight have been seen with a longer follow-up. The pericar-
ium was left open after CABG surgery in this group of
atients, which could influence biventricular filling patterns.
owever, no significant effect was observed in a study by
indstrom and colleagues,37 in which a pericardial patch
as used.
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A
CDABLE E1. Transmitral inflow–derived variables
Peak velocity (cm/s)
DT (ms) A duration (ms)n E wave A wave E/A ratio
reoperative
Total 46 68.3 17.0 83.3 21.6 0.88 0.39 255.6 51.3 136.0 18.7
Milrinone 22 73.7 16.9 79.2 18.2 0.97 0.30‡ 243.1 55.1 130.9 17.6‡
Placebo 24 62.3 14.9 85.1 24.3 0.81 0.46 263.5 45.2 141.0 19.8
8 h
Total 44 85.2 19.1* 70.8 17.6* 1.27 0.47* 183.1 50.0* 121.8 16.5*
Milrinone 21 85.9 18.9* 64.5 17.0* 1.44 0.57*‡ 174.2 43.6* 118.4 17.0*‡
Placebo 23 84.6 19.7* 77.1 16.1* 1.11 0.25* 191.6 55.2* 125.3 15.7*
mo
Total 21 65.1 14.0† 81.7 16.3 0.82 0.21† 236.3 42.3† 127.9 19.9§
Milrinone 9 67.4 7.8† 82.7 15.2 0.86 0.26†‡ 244.1 47.5† 122.4 21.3‡§
Placebo 12 63.3 17.4† 80.9 17.8 0.79 0.17† 230.4 39.2† 131.9 18.6§
, Early mitral filling E-wave velocity; A, atrial filling A-wave velocity; DT, E-wave deceleration time. *P  .05 for 48 hours versus preoperative stage. †P  .05
or 6 months versus 48 hours. ‡P  .05 between treatment groups. §P  .05 for 6 months versus preoperative stage.
ABLE E2. Pulmonary venous flow–derived variables
Peak velocity (cm/s) Ar duration
(ms)n S wave D wave S/D Ar
reoperative
Total 45 50.1 12.3 44.7 12.4 1.19 0.43 29.6 5.0 114.3 27.8
Milrinone 22 50.2 10.0 44.7 13.6 1.19 0.31 30.0 5.3 108.9 27.2
Placebo 23 50.1 14.7 44.2 12.1 1.22 0.53 29.5 4.9 116.1 23.1
8 h
Total 41 46.4 12.4 55.0 14.6* 0.87 0.29* 27.9 7.4 93.7 24.1*
Milrinone 20 47.8 15.2 55.5 11.6* 0.89 0.33* 28.1 8.9 102.6 26.3*
Placebo 21 45.1 9.3 54.6 17.2* 0.86 0.22* 27.8 6.0 85.2 18.7*
mo
Total 20 53.4 13.2 43.3 8.2† 1.25 0.27† 27.3 5.4 91.4 18.6‡
Milrinone 9 57.9 11.7 45.3 10.1† 1.31 0.25†‡ 28.0 6.9 94.7 25.1‡
Placebo 11 49.7 13.7 41.6 6.3† 1.20 0.29†‡ 26.7 4.0 88.4 10.6‡
, Systolic S-wave velocity; D, diastolic-D wave velocity; Ar, reversed A-wave velocity. *P  .05 for 48 hours versus preoperative stage. †P  .05 for 6
onths versus 48 hours. ‡P  .05 for 6 months versus preoperative stage.
ABLE E3. Tissue Doppler imaging velocities from lateral mitral annulus
n Em (cm/s) Am (cm/s) Em/Am ratio E/Em ratio (n)
reoperative
Total 46 8.5 2.3 11.7 3.2 0.76  0.25 8.6  3.2 (43)
Milrinone 22 9.0 2.4‡ 11.5 2.8 0.81 0.20‡ 8.6 2.8 (21)
Placebo 24 8.1 2.4 12.0 3.7 0.73 0.30 8.4  3.6 (22)
8 h
Total 41 9.3 2.0 12.1 3.9 0.87 0.43 9.8  3.2* (39)
Milrinone 19 9.8 2.2‡ 10.8 2.9 1.02 0.53‡ 9.6 3.1* (19)
Placebo 22 8.9 1.8 13.2 4.4 0.74 0.27 9.9  3.3* (20)
mo
Total 21 9.3 1.7 11.8 2.9 0.83 0.26 7.2  1.9†§ (21)
Milrinone 9 10.6 1.1‡ 11.8 2.4 0.93  0.23‡ 6.5 1.0†§ (9)
Placebo 12 8.4 1.6 11.8 3.3 0.77 0.27 7.7  2.3†§ (12)
m, Early mitral annular velocity; Am, Late mitral annular velocity; E, early trans-mitral filling E-wave velocity. *P  .05 for 48 hours versus preoperative
tage. †P  .05 for 6 months versus 48 hours. ‡P  .05 between treatment groups. §P  .05 for 6 months versus preoperative stage and 48 hours.
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1
A
CDABLE E4. Left ventricular isovolumic relaxation time and mitral valve propagation velocity
n IVRT, IVRT/(RR)1/2 (ms) n Vp (cm/s) E/Vp ratio n
reoperative
Total 46 103.0 23.6, 3.32 0.73 43 47.1 17.7 1.56 0.61 46
Milrinone 22 97.0 17.8, 3.07 0.51 21 45.3  11.3 1.71 0.65 22
Placebo 24 107.3 28.1, 3.48 0.86 22 50.6 22.3 1.34 0.50 24
8 h
Total 45 71.7 14.1*, 2.66 0.54 40 78.6 27.3* 1.18 0.44* 40
Milrinone 21 71.1 13.2*, 2.62 0.54* 19 70.2 16.0* 1.27 0.37* 19
Placebo 24 72.2 15.1*, 2.69 0.55* 21 86.3 33.1* 1.09 0.50* 21
mo
Total 21 94.0 14.9†, 3.18 0.51 21 55.1 20.4† 1.30 0.44 21
Milrinone 9 91.2 13.0†, 3.13 0.59† 9 57.1 24.4† 1.33 0.42 9
Placebo 12 96.0 16.4†, 3.21 0.47† 12 53.6 17.8† 1.28 0.47 12
VRT, Isovolumic relaxation time; RR, R-R interval in milliseconds derived from simultaneously recorded electrocardiograms; Vp, propagation velocity;
, early mitral filling E-wave velocity. *P  .05 for 48 hours versus preoperative stage. †P  .05 for 6 months versus 48 hours.ABLE E5. Transtricuspid inflow–derived variables
Peak velocity (cm/s)
DT (ms)n E wave A wave E/A ratio
reoperative
Total 44 47.2 9.8 46.1  12.6 1.06  0.24 229.7  56.1
Milrinone 20 48.2 9.1 45.9  14.0 1.11 0.26‡ 236.7 71.0
Placebo 24 45.9 10.7 46.3 11.5 1.02 0.22 223.8  43.6
8 h
Total 41 53.6 11.8* 48.5 14.4 1.16 0.31 184.5  52.3*
Milrinone 19 53.0 13.0* 45.4 13.4 1.23 0.34‡ 190.8 59.1*
Placebo 22 54.1 10.8* 51.5 15.1 1.09 0.26 179.0  46.3*
mo
Total 21 55.0 10.2§ 41.2 7.1 1.37  0.33†§ 174.1 44.9§
Milrinone 9 58.6 9.2§ 41.0 6.9 1.46  0.32†‡§ 177.9 41.8§
Placebo 12 52.3 10.4§ 41.4 7.6 1.30  0.32†§ 171.2 48.9§
, Early tricuspid filling E-wave velocity; A, atrial filling A-wave velocity; DT, tricuspid E-wave deceleration time. *P  .05 for 48 hours versus preoperative
tage. †P  .05 for 6 months versus 48 hours. ‡P  .05 between treatment groups. §P  .05 for 6 months versus preoperative stage.ABLE E6. Hepatic venous flow–derived velocities
Peak velocity (cm/s)
n S wave D wave S/D Ar
reoperative
Total 36 49.6 21.0 38.3  14.3 1.30 0.37 33.1  8.5
Milrinone 19 50.2 18.4 39.9  15.0 1.31 0.35 32.5  11.3
Placebo 17 49.4 25.3 36.3  14.0 1.31 0.40 33.8  5.3
8 h
Total 17 34.4 12.5* 42.8 18.7 0.85 0.35* 29.5 8.0
Milrinone 10 34.3 11.5* 40.6 23.9 0.82 0.40* 29.1 8.0
Placebo 7 34.6 14.8* 42.8 18.7 0.90 0.27* 29.8 8.4
mo
Total 19 47.1 26.3† 38.8 25.2 1.26 0.28† 30.3 8.5
Milrinone 8 60.8 32.9† 50.3 34.5 1.27 0.20† 32.4 7.4
Placebo 11 37.1 15.2† 30.6 11.3 1.25 0.33† 28.7 9.3
, Systolic S-wave velocity; D, diastolic D-wave velocity; Ar, reversed A-wave velocity. *P  .05 for 48 hours versus preoperative stage. †P  .05 for 6
onths versus 48 hours.
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A
CDABLE E7. TDI velocities from lateral tricuspid annulus
n Et (cm/s) At (cm/s) Et/At ratio
Preoperative
Total 46 9.3 2.7 14.9  3.8 0.63 0.11
Milrinone 22 9.6 2.1 15.7  3.4 0.62 0.10
Placebo 24 9.3 3.2 14.5  4.3 0.64 0.12
48 h
Total 37 7.3 2.5* 9.3 3.1* 0.83 0.36*
Milrinone 17 7.2 2.5* 9.0 2.9* 0.88 0.46*
Placebo 20 7.5 2.5* 9.7 3.2* 0.78 0.25*
6 mo
Total 19 6.4 1.3‡ 10.2 1.9‡ 0.64 0.18†
Milrinone 9 6.0 1.1‡ 9.8 1.8‡ 0.62 0.13†
Placebo 10 6.8 1.3‡ 10.6 1.9‡ 0.66 0.22†
DI, Tissue Doppler imaging; Et, early filling tricuspid annular velocity; At, atrial filling tricuspid annular velocity. *P  .05 for 48 hours versus preoperative
tage. †P  .05 for 6 months versus 48 hours. ‡P  .05 for 6 months versus preoperative stage.The Journal of Thoracic and Cardiovascular Surgery ● Volume 131, Number 5 1086.e3
